H.R. 2533 · 117th Congress · House

NEAR Act of 2021

In Congress· Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
Introduced
Apr 14, 21
Passed House
May 18, 21
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
H.Res. 403
117th Congress
Providing for consideration of the bill (H.R. 1629) to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes; providing for consideration of the resolution (H. Res. 275) condemning the horrific shootings in Atlanta, Georgia, on March 16, 2021, and reaffirming the House of Representative's commitment to combating hate, bigotry, and violence against the Asian-American and Pacific Islander community; and for other purposes.

Motion to reconsider laid on the table Agreed to without objection.

Related bill
by House
May 18, 2021
H.Res. 403
117th Congress
Providing for consideration of the bill (H.R. 1629) to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes; providing for consideration of the resolution (H. Res. 275) condemning the horrific shootings in Atlanta, Georgia, on March 16, 2021, and reaffirming the House of Representative's commitment to combating hate, bigotry, and violence against the Asian-American and Pacific Islander community; and for other purposes.

Motion to reconsider laid on the table Agreed to without objection.

Related bill
by House
May 18, 2021